Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Pathologie-Biologie
|
December 28, 1999
[Pediatric liver diseases]
P Labrune, A Myara, F Imbert-Bismut, et al.
Annales De Biologie Clinique
|
October 14, 1998
[Role of biology in the follow up of viral hepatitis]
A Myara, F Imbert-Bismut, A Piton, et al.
Annales De Biologie Clinique
|
January 1, 1996
[Adaptation of the measurement of plasma and erythrocyte glutathione peroxidase activity on Hitachi 911]
S Dever, C Vegas, F Imbert-Bismut, et al.
Annales De Biologie Clinique
|
January 28, 1999
[Chromatic interferences reduction by near infrared spectrophotometry: application on clinical biochemistry analyzer]
A Piton, O Marais, F Imbert-Bismut, et al.
Lancet (London, England)
|
April 12, 2001
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
F Imbert-Bismut, V Ratziu, L Pieroni, et al.
Annales De Medecine Interne
|
October 16, 1999
[Macro-aspartate aminotransferase: a benign biological anomaly to consider]
A Teixeira-Ribeiro, T Généreau, M Devanlay, et al.
Clinical Chemistry
|
October 24, 2001
Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration
L Pieroni, L Khalil, F Charlotte, et al.
Annales De Biologie Clinique
|
August 3, 2005
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]
A Piton, D Messous, F Imbert-Bismut, et al.
Journal of Viral Hepatitis
|
June 9, 2012
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab
G Geri, B Terrier, F Imbert-Bismut, et al.
Hepatology (Baltimore, Md.)
|
May 15, 1998
Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group
A Piton, T Poynard, F Imbert-Bismut, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Pathologie-Biologie
|
December 28, 1999
[Pediatric liver diseases]
P Labrune, A Myara, F Imbert-Bismut, et al.
Annales De Biologie Clinique
|
October 14, 1998
[Role of biology in the follow up of viral hepatitis]
A Myara, F Imbert-Bismut, A Piton, et al.
Annales De Biologie Clinique
|
January 1, 1996
[Adaptation of the measurement of plasma and erythrocyte glutathione peroxidase activity on Hitachi 911]
S Dever, C Vegas, F Imbert-Bismut, et al.
Annales De Biologie Clinique
|
January 28, 1999
[Chromatic interferences reduction by near infrared spectrophotometry: application on clinical biochemistry analyzer]
A Piton, O Marais, F Imbert-Bismut, et al.
Lancet (London, England)
|
April 12, 2001
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
F Imbert-Bismut, V Ratziu, L Pieroni, et al.
Annales De Medecine Interne
|
October 16, 1999
[Macro-aspartate aminotransferase: a benign biological anomaly to consider]
A Teixeira-Ribeiro, T Généreau, M Devanlay, et al.
Clinical Chemistry
|
October 24, 2001
Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration
L Pieroni, L Khalil, F Charlotte, et al.
Annales De Biologie Clinique
|
August 3, 2005
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]
A Piton, D Messous, F Imbert-Bismut, et al.
Journal of Viral Hepatitis
|
June 9, 2012
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab
G Geri, B Terrier, F Imbert-Bismut, et al.
Hepatology (Baltimore, Md.)
|
May 15, 1998
Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group
A Piton, T Poynard, F Imbert-Bismut, et al.
Page
of 3